Archive for 2013

Stephen Epstein, MD To Head Scientific & Medical Advisory Board…

Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that cardiologist Stephen E. Epstein, MD, Director of Translational…(PRWeb March 04, 2013)Read the full story at htt…


The Research Triangle Park Announces New Partnerships and Event Series…

The Research Triangle Park has just announced two new partnerships and an event series in support of a regional entrepreneurial initiative.(PRWeb March 04, 2013)Read the full story at http://www.prweb.com/releases/2013/3/prweb10486051.htm


100% Identification of Defective Blister Packs by Sepha’s…

A new whitepaper published by Dr. Dorian Dixon, a leading packaging expert at the University of Ulster in Northern Ireland has shown that VisionScan, which is a non-destructive seal and leak detection…(PRWeb March 04, 2013)Read the full story at h…


Drug Patent Expirations for Feb 22 2013

If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations

Advertise
here

This newsletter is
a free service of DrugPatentWatch

DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents





Drug Patent Expirations for February 22 2013

Tradename Applicant Generic Name Patent
Expiration
ABRAXANE Abraxis Bioscience paclitaxel Feb 22, 2013

*Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details.



DrugPatentWatch
Infographics

Which patents protect the most drugs

Which Patents Cover the Most
Drugs?

More
infographics &raquo





DrugPatentWatch Serves Your Competitive Intelligence
Needs

Subscribers have
access to valuable datasets, including:
  • Patent litigation
  • Clinical trial information
  • International patent families
  • International patent priority and PCT
    information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Drug Master Files
  • Dynamic search capabilities with data
    export
  • More…
See the Database
Preview
and Plan
Comparison
. Contact Us with any
questions.





The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details

DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.


Ethylene Market 2017 Forecasts for 6 Countries in New Research &…

Ethylene industry outlook to 2017 with data and analysis on market size, company share, price trends, capacity forecasts of all active and planned plants in India, China, Japan, Korea, US and Russia…(PRWeb March 03, 2013)Read the full story at htt…


New Information from Bloomberg.com reports Brazilian Bikini Waxing…

A recent article from Bloomberg.com sheds light on a waxing trend in men and women that is killing off the pubic lice species known as Crabs, but may cause damage and Bacteria infections in the skin….(PRWeb March 02, 2013)Read the full story at ht…


China Market Data: Acrylonitrile, Phytol and Branched Chain Amino…

Chinese markets for BCAAs, Phytol and Acrylonitrile reviewed with critical primary intelligence data in new industry research reports by CCM International available at RnR Market Research.(PRWeb March 01, 2013)Read the full story at http://www.prweb…